A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study-Reference-Cited by-同舟云学术

A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study

Published:2009-11 Issue:2 Volume:115 Page:215-220
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Aghajanian Carol,Blessing John A.,Darcy Kathleen M.,Reid Gary,DeGeest Koen,Rubin Stephen C.,Mannel Robert S.,Rotmensch Jacob,Schilder Russell J.,Riordan William

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference38 articles.

1. New insights into proteasome function: from Archaebacteria to drug development;Goldberg;Chem. Biol.,1995

2. The ubiquitin–proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB;Palombella;Cell,1994

3. An essential role for NF-κB in preventing TNF-α-induced cell death;Beg;Science,1996

4. Suppression of TNF-α-induced apoptosis by NF-κB;Van Antwerp;Science,1996

5. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB;Wang;Science,1996

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer;PLOS ONE;2024-07-11

2. Targeting Therapeutic Resistance and Multinucleate Giant Cells in CCNE1-Amplified HR-Proficient Ovarian Cancer;Molecular Cancer Therapeutics;2022-06-23

3. Novel Perspectives in Pseudomyxoma Peritonei Treatment;Cancers;2021-11-27

4. The Dual Role of STAT1 in Ovarian Cancer: Insight Into Molecular Mechanisms and Application Potentials;Frontiers in Cell and Developmental Biology;2021-03-23

5. Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis;Biomarker Research;2020-09-15